Аннотация
C Hepatitis is one of the most common reason of persist viral infection of the liver, chronic hepatitis, Liver cirrhosis and/ or Hepatocellular Carcinoma worldwide. It is very important to reveal cases of acute hepatitis timely and to establish route of transmission, that on the one hand will prevent the future prevalence of the disease. The aim of the research was to reveal clinical-epidemiological peculiarities of cases acute hepatitis C. In 20132015 years 31 patients were hospitalized with diagnosis of acute C hepatitis According to epidemiological anamnesis the main causes of spreading infection remain invasive medical and stomatological manipulations, intravenous drug injections. It is worthy to note that in high percentage of patients the route of transmission wasn’t revealed. – this proves significance of different manipulations as causative agents in further increase of infected patients.
Библиографические ссылки
2. Averhoff FM, Glass N, Holtzman D. Global burden of hepatitis C: considerations for healthcare providers in the United States. Clin Infect Dis. 2012 Jul;55 Suppl 1:S10–5.
3. CDC. Testing for HCV infection: an update of guidance for clinicians and laboratorians. MMWR Morb Mortal Wkly Rep. 2013 May 10;62(18):362–5.
4. Cooke GS, Lemoine M, Thursz M, Gore C, Swan T, Kamarulzaman A, et al. Viral hepatitis and the Global Burden of Disease: J Viral Hepat. 2013;20:600–601.
5. Gower E, Estes C, Blach S, Razavi-Shearer K Razavi H Global epidemiology and genotype distribution of the hepatitis C virus infection. J Hepatol. 2014 Nov;61(1 Suppl):S4557. doi: 10.1016/j.jhep.2014.07.027. Epub 2014 Jul 30.
6. Lavanchy D. Evolving epidemiology of hepatitis C virus. Clin Microbiol Infect 2011;17:107–115.
7. Mohd Hanafiah K, Groeger J, Flaxman AD, Wiersma ST. Global epidemiology of hepatitis C virus infection: new estimates of age-specific antibody to HCV seroprevalence. Hepatology. 2013 Apr;57(4):1333–42.
8. Razavi H, ElKhoury AC, Elbasha E, Estes C, Pasini K, Poynard T, et al. Chronic hepatitis C virus (HCV) disease burden and cost in the United States. Hepatology. 2013;57:2164–2170.